NASDAQ:DXCM - Dexcom Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$86.91 +0.26 (+0.30 %)
(As of 05/22/2018 03:45 AM ET)
Previous Close$86.65
Today's Range$86.0350 - $87.85
52-Week Range$42.62 - $88.60
Volume336,313 shs
Average Volume1.25 million shs
Market Capitalization$7.63 billion
P/E Ratio-149.84
Dividend YieldN/A
Beta0.01

About Dexcom (NASDAQ:DXCM)

Dexcom logoDexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers. Its products include DexCom G5 mobile continuous glucose monitoring system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC to develop a series of next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Receive DXCM News and Ratings via Email

Sign-up to receive the latest news and ratings for DXCM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:DXCM
CUSIP25213110
Phone858-200-0200

Debt

Debt-to-Equity Ratio0.79
Current Ratio5.83
Quick Ratio5.42

Price-To-Earnings

Trailing P/E Ratio-149.84
Forward P/E Ratio-167.13
P/E GrowthN/A

Sales & Book Value

Annual Sales$718.50 million
Price / Sales10.65
Cash FlowN/A
Price / CashN/A
Book Value$4.83 per share
Price / Book17.99

Profitability

EPS (Most Recent Fiscal Year)($0.58)
Net Income$-50,200,000.00
Net Margins-4.30%
Return on Equity-9.32%
Return on Assets-4.28%

Miscellaneous

Employees2,990
Outstanding Shares88,080,000

Dexcom (NASDAQ:DXCM) Frequently Asked Questions

What is Dexcom's stock symbol?

Dexcom trades on the NASDAQ under the ticker symbol "DXCM."

How were Dexcom's earnings last quarter?

Dexcom (NASDAQ:DXCM) announced its earnings results on Wednesday, May, 2nd. The medical device company reported ($0.32) earnings per share (EPS) for the quarter, meeting the Zacks' consensus estimate of ($0.32). The medical device company had revenue of $184.40 million for the quarter, compared to analyst estimates of $172.66 million. Dexcom had a negative return on equity of 9.32% and a negative net margin of 4.30%. Dexcom's quarterly revenue was up 29.6% on a year-over-year basis. During the same period in the prior year, the company posted ($0.49) EPS. View Dexcom's Earnings History.

When is Dexcom's next earnings date?

Dexcom is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Dexcom.

What price target have analysts set for DXCM?

19 equities research analysts have issued 12-month price targets for Dexcom's shares. Their predictions range from $40.00 to $100.00. On average, they anticipate Dexcom's stock price to reach $69.7941 in the next twelve months. View Analyst Ratings for Dexcom.

Are investors shorting Dexcom?

Dexcom saw a drop in short interest during the month of April. As of April 13th, there was short interest totalling 12,600,819 shares, a drop of 10.9% from the March 30th total of 14,147,733 shares. Based on an average trading volume of 1,326,047 shares, the days-to-cover ratio is currently 9.5 days. Approximately 14.9% of the shares of the stock are sold short.

Who are some of Dexcom's key competitors?

Who are Dexcom's key executives?

Dexcom's management team includes the folowing people:
  • Mr. Kevin R. Sayer, Chief Exec. Officer, Pres and Director (Age 60)
  • Mr. Steven R. Pacelli, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Richard B. Doubleday, Chief Commercial Officer and Exec. VP (Age 55)
  • Mr. Donald M. Abbey, Exec. VP of Quality & Regulatory Affairs (Age 51)
  • Mr. Terrance H. Gregg, Exec. Chairman (Age 69)

Has Dexcom been receiving favorable news coverage?

Headlines about DXCM stock have trended somewhat positive on Tuesday, according to Accern. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dexcom earned a news sentiment score of 0.05 on Accern's scale. They also assigned press coverage about the medical device company an impact score of 46.02 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Dexcom's major shareholders?

Dexcom's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (6.15%), BlackRock Inc. (4.41%), JPMorgan Chase & Co. (2.94%), OppenheimerFunds Inc. (1.70%), Franklin Resources Inc. (1.33%) and Point72 Asset Management L.P. (1.11%). Company insiders that own Dexcom stock include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Jeffrey Moy, Jess Roper, John Lister, Jonathan T Md Lord, Jorge A Valdes, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven R Altman, Steven Robert Pacelli and Terrance H Gregg. View Institutional Ownership Trends for Dexcom.

Which major investors are selling Dexcom stock?

DXCM stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, Russell Investments Group Ltd., Massachusetts Financial Services Co. MA, Baillie Gifford & Co., Compagnie Lombard Odier SCmA, Thornburg Investment Management Inc., Allianz Asset Management GmbH and Blair William & Co. IL. Company insiders that have sold Dexcom company stock in the last year include Andrew K Balo, Barbara Kahn, Jacob Steven Leach, Jay S Skyler, Kevin R Sayer, Mark G Foletta, Richard Doubleday, Steven Robert Pacelli and Terrance H Gregg. View Insider Buying and Selling for Dexcom.

Which major investors are buying Dexcom stock?

DXCM stock was bought by a variety of institutional investors in the last quarter, including Rockefeller Capital Management L.P., Point72 Asset Management L.P., Neuberger Berman Group LLC, Federated Investors Inc. PA, JPMorgan Chase & Co., Columbus Circle Investors, Frontier Capital Management Co. LLC and Chicago Capital LLC. View Insider Buying and Selling for Dexcom.

How do I buy shares of Dexcom?

Shares of DXCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dexcom's stock price today?

One share of DXCM stock can currently be purchased for approximately $86.91.

How big of a company is Dexcom?

Dexcom has a market capitalization of $7.63 billion and generates $718.50 million in revenue each year. The medical device company earns $-50,200,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Dexcom employs 2,990 workers across the globe.

How can I contact Dexcom?

Dexcom's mailing address is 6340 SEQUENCE DRIVE, SAN DIEGO CA, 92121. The medical device company can be reached via phone at 858-200-0200 or via email at [email protected]


MarketBeat Community Rating for Dexcom (DXCM)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  585 (Vote Outperform)
Underperform Votes:  306 (Vote Underperform)
Total Votes:  891
MarketBeat's community ratings are surveys of what our community members think about Dexcom and other stocks. Vote "Outperform" if you believe DXCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXCM will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dexcom (NASDAQ:DXCM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
21 Wall Street analysts have issued ratings and price targets for Dexcom in the last 12 months. Their average twelve-month price target is $69.7941, suggesting that the stock has a possible downside of 19.69%. The high price target for DXCM is $100.00 and the low price target for DXCM is $40.00. There are currently 2 sell ratings, 7 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.482.502.572.64
Ratings Breakdown: 2 Sell Rating(s)
7 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $69.7941$67.3824$67.4412$70.6944
Price Target Upside: 19.69% downside6.09% downside24.09% upside48.14% upside

Dexcom (NASDAQ:DXCM) Consensus Price Target History

Price Target History for Dexcom (NASDAQ:DXCM)

Dexcom (NASDAQ:DXCM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/11/2018Bank of AmericaInitiated CoverageBuy ➝ Buy$100.00MediumView Rating Details
5/4/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $70.00N/AView Rating Details
5/3/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$81.00 ➝ $85.00HighView Rating Details
5/3/2018OppenheimerBoost Price TargetOutperform$80.00 ➝ $85.00HighView Rating Details
5/3/2018BMO Capital MarketsBoost Price TargetOutperformer ➝ Outperformer$78.00 ➝ $86.00HighView Rating Details
5/3/2018BTIG ResearchReiterated RatingHoldHighView Rating Details
4/9/2018StephensReiterated RatingBuy$78.00MediumView Rating Details
4/4/2018Goldman SachsInitiated CoverageSell ➝ Sell$74.69 ➝ $57.00HighView Rating Details
4/3/2018GuggenheimInitiated CoverageNeutral ➝ NeutralHighView Rating Details
3/29/2018Piper Jaffray CompaniesSet Price TargetBuy$80.00MediumView Rating Details
3/23/2018Robert W. BairdUpgradeNeutral ➝ Outperform$58.00HighView Rating Details
3/4/2018Northcoast ResearchReiterated RatingBuyHighView Rating Details
1/16/2018Northland SecuritiesReiterated RatingSell$40.00LowView Rating Details
1/8/2018BarclaysReiterated RatingHold$60.00HighView Rating Details
12/22/2017Jefferies GroupBoost Price TargetTop Pick ➝ Buy$58.00 ➝ $70.00LowView Rating Details
10/4/2017WedbushReiterated RatingBuy$76.00LowView Rating Details
9/29/2017Leerink SwannReiterated RatingBuy$85.00 ➝ $57.00HighView Rating Details
9/29/2017Raymond JamesDowngradeOutperform ➝ Mkt PerformHighView Rating Details
9/28/2017CowenLower Price TargetOutperform$90.00 ➝ $64.00HighView Rating Details
9/28/2017CitigroupDowngradeOutperform ➝ Market PerformHighView Rating Details
9/28/2017JPMorgan ChaseDowngradeOverweight ➝ Neutral$93.00 ➝ $71.00HighView Rating Details
5/7/2017B. RileyReiterated RatingBuy$95.00HighView Rating Details
4/27/2017William BlairReiterated RatingOutperformLowView Rating Details
4/4/2017Royal Bank of CanadaReiterated RatingOutperform$87.00MediumView Rating Details
12/19/2016UBSUpgradeMarket Perform ➝ OutperformN/AView Rating Details
9/16/2016DesjardinsUpgradeHold ➝ BuyN/AView Rating Details
8/3/2016BenchmarkLower Price TargetBuy$106.00 ➝ $86.00N/AView Rating Details
7/15/2016Deutsche BankBoost Price TargetBuy$90.00 ➝ $98.00N/AView Rating Details
(Data available from 5/22/2016 forward)

Earnings

Dexcom (NASDAQ:DXCM) Earnings History and Estimates Chart

Earnings by Quarter for Dexcom (NASDAQ:DXCM)

Dexcom (NASDAQ:DXCM) Earnings Estimates

2018 EPS Consensus Estimate: ($0.39)
2019 EPS Consensus Estimate: ($0.18)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20186($0.43)($0.13)($0.30)
Q2 20187($0.26)$0.05($0.17)
Q3 20187($0.16)$0.15($0.03)
Q4 20187($0.01)$0.28$0.10
Q1 20193($0.35)($0.03)($0.22)
Q2 20193($0.15)($0.02)($0.08)
Q3 20193($0.01)$0.02$0.01
Q4 20193$0.01$0.20$0.10

Dexcom (NASDAQ DXCM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/30/2018($0.19)N/AView Earnings Details
5/2/2018Q1 2018($0.32)($0.32)$172.66 million$184.40 millionViewListenView Earnings Details
2/27/2018Q4 2017$0.03$0.10$217.82 million$221.00 millionViewListenView Earnings Details
11/1/2017Q3 2017($0.15)($0.04)$183.42 million$184.60 millionViewN/AView Earnings Details
8/1/2017Q2 2017($0.23)($0.16)$166.54 million$170.60 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.55)($0.49)$143.94 million$142.30 millionViewListenView Earnings Details
2/28/2017Q416($0.10)($0.09)$167.51 million$171.20 millionViewListenView Earnings Details
11/1/2016Q316($0.14)($0.22)$146.09 million$148.60 millionViewN/AView Earnings Details
8/2/2016Q216($0.12)($0.24)$132.48 million$137.30 millionViewN/AView Earnings Details
4/27/2016Q116($0.20)($0.23)$110.37 million$116.20 millionViewListenView Earnings Details
2/23/2016Q415$0.01$0.02$122.93 million$130.80 millionViewListenView Earnings Details
11/4/2015Q315($0.01)($0.07)$97.47 million$105.20 millionViewN/AView Earnings Details
8/5/2015Q215($0.03)($0.05)$84.74 million$93.20 millionViewN/AView Earnings Details
4/29/2015Q115($0.11)($0.17)$71.32 million$72.80 millionViewN/AView Earnings Details
2/25/2015Q414($0.03)$0.02$79.65 million$84.30 millionViewN/AView Earnings Details
11/6/2014Q314($0.05)($0.08)$60.20 million$67.90 millionViewN/AView Earnings Details
8/6/2014Q214($0.10)($0.10)$52.45 million$58.80 millionViewListenView Earnings Details
5/1/2014Q114($0.08)($0.17)$44.15 million$47.10 millionViewListenView Earnings Details
2/20/2014Q413($0.07)($0.04)$48.53 million$51.30 millionViewListenView Earnings Details
11/6/2013Q313($0.13)($0.09)$35.90 million$42.90 millionViewN/AView Earnings Details
8/7/2013Q2 2013($0.16)($0.14)$31.14 million$35.80 millionViewN/AView Earnings Details
5/1/2013Q1 2013($0.17)($0.16)$28.26 million$29.60 millionViewN/AView Earnings Details
2/21/2013Q4 2012($0.15)($0.12)$31.09 million$33.30 millionViewN/AView Earnings Details
11/1/2012Q312($0.22)($0.25)$23.14 million$23.10 millionViewN/AView Earnings Details
8/6/2012($0.20)($0.21)ViewN/AView Earnings Details
5/2/2012($0.19)($0.21)ViewN/AView Earnings Details
2/23/2012($0.17)($0.18)ViewN/AView Earnings Details
11/2/2011($0.15)($0.20)ViewN/AView Earnings Details
8/3/2011($0.11)($0.11)ViewN/AView Earnings Details
5/3/2011($0.19)($0.19)ViewN/AView Earnings Details
3/3/2011($0.19)($0.16)ViewN/AView Earnings Details
11/4/2010Q3 2010($0.17)($0.23)ViewN/AView Earnings Details
8/3/2010Q2 2010($0.20)($0.20)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.24)($0.27)ViewN/AView Earnings Details
3/9/2010Q4 2009($0.27)($0.25)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.32)($0.29)ViewN/AView Earnings Details
8/3/2009Q2 2009($0.29)($0.33)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.32)($0.30)ViewN/AView Earnings Details
3/5/2009Q4 2008($0.44)($0.45)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.46)($0.50)ViewN/AView Earnings Details
8/5/2008Q2 2008($0.46)($0.48)ViewN/AView Earnings Details
5/8/2008Q1 2008($0.39)($0.44)ViewN/AView Earnings Details
3/11/2008Q4 2007($0.41)($0.43)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Dexcom (NASDAQ:DXCM) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Dexcom (NASDAQ DXCM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.80%
Insider Trading History for Dexcom (NASDAQ:DXCM)
Institutional Ownership by Quarter for Dexcom (NASDAQ:DXCM)

Dexcom (NASDAQ DXCM) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2018Terrance H GreggInsiderSell10,000$85.90$859,000.00511,674View SEC Filing  
5/14/2018Jay S SkylerDirectorSell30,000$88.00$2,640,000.004,553View SEC Filing  
5/9/2018Kevin R SayerCEOSell17,245$84.37$1,454,960.65366,635View SEC Filing  
5/8/2018Jacob Steven LeachSVPSell1,923$84.95$163,358.85100,801View SEC Filing  
5/8/2018Jay S SkylerDirectorSell31,464$85.11$2,677,901.044,553View SEC Filing  
4/23/2018Richard DoubledayEVPSell2,581$73.09$188,645.2994,429View SEC Filing  
4/16/2018Terrance H GreggInsiderSell10,000$73.04$730,400.00521,674View SEC Filing  
3/23/2018Richard DoubledayEVPSell2,581$68.44$176,643.6494,429View SEC Filing  
3/15/2018Terrance H GreggInsiderSell10,000$65.51$655,100.00521,674View SEC Filing  
2/23/2018Richard DoubledayEVPSell1,638$56.32$92,252.1665,049View SEC Filing  
2/15/2018Terrance H GreggChairmanSell10,000$55.91$559,100.00484,559View SEC Filing  
1/23/2018Richard DoubledayEVPSell1,635$54.67$89,385.4565,049View SEC Filing  
1/16/2018Terrance H GreggInsiderSell10,000$56.86$568,600.00484,559View SEC Filing  
12/26/2017Richard DoubledayEVPSell1,635$56.39$92,197.6565,049View SEC Filing  
12/12/2017Kevin R. SayerCEOSell6,000$58.85$353,100.00View SEC Filing  
12/11/2017Andrew K. BaloEVPSell3,245$61.23$198,691.35View SEC Filing  
11/29/2017Andrew K. BaloEVPSell6,490$60.00$389,400.00View SEC Filing  
11/27/2017Mark G FolettaDirectorSell2,500$54.95$137,375.004,952View SEC Filing  
11/24/2017Richard DoubledayEVPSell1,635$55.53$90,791.5565,049View SEC Filing  
11/20/2017Barbara KahnDirectorSell3,000$54.58$163,740.004,353View SEC Filing  
11/20/2017Kevin R. SayerCEOSell12,000$55.00$660,000.00View SEC Filing  
11/6/2017Steven R AltmanDirectorBuy10,000$49.61$496,100.004,353View SEC Filing  
10/23/2017Richard DoubledayEVPSell1,635$44.82$73,280.7065,049View SEC Filing  
9/25/2017Steven Robert PacelliEVPSell1,450$69.81$101,224.50View SEC Filing  
9/20/2017Kevin R. SayerCEOSell6,000$69.34$416,040.00View SEC Filing  
9/11/2017Andrew K. BaloEVPSell3,244$72.27$234,443.88View SEC Filing  
8/23/2017Richard DoubledayEVPSell1,635$75.26$123,050.1072,395View SEC Filing  
8/11/2017Kevin R. SayerCEOSell6,000$69.77$418,620.00View SEC Filing  
8/10/2017Andrew K. BaloEVPSell3,244$71.18$230,907.92View SEC Filing  
7/24/2017Steven Robert PacelliEVPSell1,450$69.47$100,731.50View SEC Filing  
7/12/2017Kevin R. SayerCEOSell6,000$71.86$431,160.00View SEC Filing  
7/10/2017Andrew K. BaloEVPSell3,200$71.55$228,960.00View SEC Filing  
6/23/2017Steven Robert PacelliEVPSell1,450$78.19$113,375.50View SEC Filing  
6/12/2017Andrew K. BaloEVPSell3,200$69.06$220,992.00View SEC Filing  
6/12/2017Kevin R. SayerCEOSell6,000$69.07$414,420.00View SEC Filing  
5/23/2017Richard DoubledayEVPSell3,182$68.29$217,298.7872,395View SEC Filing  
5/17/2017Kevin R SayerCEOSell8,649$68.39$591,505.11347,329View SEC Filing  
5/10/2017Andrew K. BaloEVPSell3,200$71.93$230,176.00View SEC Filing  
4/24/2017Richard DoubledayEVPSell3,182$75.78$241,131.9697,815View SEC Filing  
4/20/2017Terrance H GreggInsiderSell15,000$74.10$1,111,500.00454,559View SEC Filing  
4/17/2017Kevin R SayerCEOSell10,000$75.63$756,300.00353,680View SEC Filing  
4/10/2017Andrew K. BaloEVPSell3,200$78.19$250,208.00View SEC Filing  
3/23/2017Richard DoubledayEVPSell3,182$76.38$243,041.1697,815View SEC Filing  
3/22/2017Jess RoperCFOSell2,000$75.97$151,940.0046,497View SEC Filing  
3/17/2017Kevin R SayerCEOSell10,000$77.82$778,200.00353,680View SEC Filing  
3/14/2017Jacob Steven LeachSVPSell21,317$77.63$1,654,838.71View SEC Filing  
3/13/2017Jorge A. ValdesInsiderSell14,400$77.74$1,119,456.00View SEC Filing  
3/9/2017John ListerInsiderSell3,000$77.67$233,010.00View SEC Filing  
3/6/2017Jay S SkylerDirectorSell31,890$78.13$2,491,565.705,011View SEC Filing  
2/23/2017Richard DoubledayEVPSell3,182$78.42$249,532.4483,582View SEC Filing  
1/23/2017Richard DoubledayEVPSell3,182$79.50$252,969.0083,582View SEC Filing  
1/18/2017Jess RoperCFOSell3,012$85.01$256,050.1255,976View SEC Filing  
1/17/2017Kevin R SayerCEOSell10,000$85.94$859,400.00309,391View SEC Filing  
1/13/2017John ListerInsiderSell15,000$79.36$1,190,400.0085,598View SEC Filing  
1/10/2017Andrew K BaloEVPSell3,200$62.86$201,152.00109,545View SEC Filing  
1/9/2017Jorge A ValdesInsiderSell10,900$63.02$686,918.0079,334View SEC Filing  
12/23/2016Richard DoubledayEVPSell3,182$62.17$197,824.9483,582View SEC Filing  
12/9/2016Jorge A ValdesInsiderSell10,000$64.81$648,100.0074,971View SEC Filing  
10/24/2016Jess RoperCFOSell2,471$80.75$199,533.25View SEC Filing  
10/24/2016Steven Robert PacelliEVPSell10,300$81.95$844,085.00View SEC Filing  
10/19/2016Andrew K. BaloEVPSell4,997$82.31$411,303.07View SEC Filing  
10/14/2016Kevin R. SayerCEOSell7,000$81.87$573,090.00View SEC Filing  
10/10/2016John ListerInsiderSell3,560$84.41$300,499.60View SEC Filing  
10/5/2016Andrew K. BaloEVPSell5,000$82.55$412,750.00View SEC Filing  
9/23/2016Richard DoubledayEVPSell3,182$93.97$299,012.5483,582View SEC Filing  
9/22/2016Jess RoperCFOSell2,470$93.99$232,155.30View SEC Filing  
9/21/2016Andrew K. BaloEVPSell5,000$92.87$464,350.00View SEC Filing  
9/14/2016Kevin R. SayerCEOSell7,000$91.79$642,530.00View SEC Filing  
9/12/2016Jay S SkylerDirectorSell10,000$93.00$930,000.005,011View SEC Filing  
9/12/2016Jorge A ValdesInsiderSell19,071$93.07$1,774,937.97103,667View SEC Filing  
9/9/2016Jay S SkylerDirectorSell25,000$94.07$2,351,750.005,011View SEC Filing  
9/9/2016John ListerInsiderSell3,560$93.65$333,394.00View SEC Filing  
9/8/2016Terrance H GreggInsiderSell10,740$95.29$1,023,414.60451,486View SEC Filing  
9/7/2016Andrew K BaloEVPSell4,999$94.45$472,155.55135,009View SEC Filing  
9/7/2016Mark G. FolettaDirectorSell1,800$94.63$170,334.00View SEC Filing  
9/1/2016Jonathan T. Md LordDirectorSell10,000$91.50$915,000.00View SEC Filing  
8/30/2016Terrance H GreggInsiderSell10,000$92.14$921,400.00451,486View SEC Filing  
8/24/2016Andrew K BaloEVPSell5,000$91.72$458,600.00134,979View SEC Filing  
8/24/2016Terrance H GreggInsiderSell10,000$92.72$927,200.00451,486View SEC Filing  
8/23/2016Steven Robert PacelliEVPSell10,300$90.74$934,622.00View SEC Filing  
8/23/2016Terrance H GreggChairmanSell10,000$91.11$911,100.00451,486View SEC Filing  
8/22/2016Terrance H GreggChairmanSell10,000$90.51$905,100.00451,486View SEC Filing  
8/19/2016Jay S SkylerDirectorSell25,000$90.77$2,269,250.005,011View SEC Filing  
8/19/2016Terrance H GreggInsiderSell40,000$90.70$3,628,000.00451,486View SEC Filing  
8/15/2016Kevin R. SayerCEOSell7,000$90.78$635,460.00View SEC Filing  
8/15/2016Terrance H GreggChairmanSell14,942$91.01$1,359,871.42451,486View SEC Filing  
8/12/2016Jonathan T. Md LordDirectorSell10,000$90.64$906,400.00View SEC Filing  
8/11/2016Terrance H GreggInsiderSell10,900$91.03$992,227.00451,486View SEC Filing  
8/10/2016Andrew K BaloEVPSell5,000$90.26$451,300.00134,979View SEC Filing  
8/9/2016Jorge A ValdesInsiderSell32,000$91.06$2,913,920.00123,667View SEC Filing  
8/9/2016Kevin R SayerCEOSell20,000$90.98$1,819,600.00362,227View SEC Filing  
8/8/2016Barbara KahnDirectorSell6,000$90.52$543,120.0012,291View SEC Filing  
8/5/2016Terrance H. GreggInsiderSell35,000$79.81$2,793,350.00View SEC Filing  
8/1/2016Jeffrey MoySVPSell15,000$92.33$1,384,950.00107,582View SEC Filing  
7/27/2016Andrew K BaloEVPSell5,000$88.14$440,700.00134,979View SEC Filing  
7/25/2016Richard DoubledayEVPSell3,182$87.31$277,820.4292,250View SEC Filing  
7/22/2016Jeffrey MoySVPSell10,000$88.48$884,800.0076,333View SEC Filing  
7/19/2016Jeffrey MoySVPSell12,843$83.78$1,075,986.54View SEC Filing  
7/13/2016Andrew K BaloEVPSell5,000$80.12$400,600.00134,979View SEC Filing  
7/13/2016Kevin R. SayerCEOSell7,000$79.92$559,440.00View SEC Filing  
7/11/2016Jorge A ValdesInsiderSell32,000$79.36$2,539,520.00123,667View SEC Filing  
6/29/2016Andrew K BaloEVPSell5,000$78.10$390,500.00134,979View SEC Filing  
6/29/2016Jeffrey MoySVPSell4,557$80.00$364,560.0076,333View SEC Filing  
6/23/2016Steven Robert PacelliEVPSell10,300$77.40$797,220.00View SEC Filing  
6/20/2016Andrew K BaloEVPSell55,000$75.00$4,125,000.00184,979View SEC Filing  
6/20/2016Jeffrey MoySVPSell7,209$77.00$555,093.0076,333View SEC Filing  
6/20/2016Kevin R. SayerCEOSell35,000$75.00$2,625,000.00View SEC Filing  
6/9/2016Jeffrey MoySVPSell6,910$74.00$511,340.0076,333View SEC Filing  
6/9/2016John ListerInsiderSell3,560$73.27$260,841.2065,894View SEC Filing  
6/8/2016Jeffrey MoySVPSell6,866$71.00$487,486.0076,333View SEC Filing  
6/8/2016Jorge A ValdesInsiderSell18,038$72.06$1,299,818.28101,667View SEC Filing  
6/8/2016Steven Robert PacelliEVPSell18,239$70.88$1,292,780.32182,518View SEC Filing  
6/7/2016Jess RoperCFOSell3,471$69.00$239,499.0085,248View SEC Filing  
5/23/2016Richard DoubledayEVPSell1,674$63.59$106,449.6694,900View SEC Filing  
5/18/2016Jorge A ValdesInsiderSell20,000$61.75$1,235,000.00111,667View SEC Filing  
5/16/2016Terrance H GreggChairmanSell20,000$62.72$1,254,400.00472,991View SEC Filing  
5/12/2016Barbara KahnDirectorSell3,000$60.72$182,160.0042,804View SEC Filing  
5/11/2016Terrance H GreggChairmanSell8,600$64.32$553,152.00472,991View SEC Filing  
5/9/2016John ListerInsiderSell3,560$62.50$222,500.0069,454View SEC Filing  
5/9/2016Terrance H GreggChairmanSell12,168$62.42$759,526.56472,991View SEC Filing  
4/27/2016Jorge A ValdesInsiderSell10,000$70.00$700,000.0091,667View SEC Filing  
4/27/2016Steven Robert PacelliEVPSell2,361$70.39$166,190.79201,757View SEC Filing  
4/25/2016Jess RoperCFOSell3,471$69.00$239,499.0088,719View SEC Filing  
4/25/2016Richard DoubledayEVPSell1,666$69.15$115,203.9094,900View SEC Filing  
4/12/2016John ListerInsiderSell3,704$65.78$243,649.1273,014View SEC Filing  
4/11/2016Terrance H GreggChairmanSell2,169$68.00$147,492.00475,159View SEC Filing  
4/4/2016Jorge A ValdesInsiderSell20,000$70.08$1,401,600.00111,667View SEC Filing  
4/4/2016Steven Robert PacelliEVPSell20,600$70.62$1,454,772.00204,118View SEC Filing  
3/31/2016Jess RoperCFOSell3,470$69.00$239,430.0092,190View SEC Filing  
3/23/2016Richard DoubledayEVPSell1,666$61.76$102,892.16123,022View SEC Filing  
3/22/2016Terrance H GreggChairmanSell25,000$59.51$1,487,750.00477,328View SEC Filing  
3/14/2016John ListerInsiderSell3,560$63.75$226,950.0080,278View SEC Filing  
3/7/2016Barbara KahnDirectorSell5,000$67.04$335,200.0045,804View SEC Filing  
2/23/2016Richard DoubledayEVPSell1,666$64.36$107,223.76100,483View SEC Filing  
2/18/2016John ListerVPSell3,560$62.50$222,500.00View SEC Filing  
1/25/2016Steven Robert PacelliEVPSell10,300$73.24$754,372.00205,914View SEC Filing  
1/22/2016Jess RoperCFOSell3,518$72.97$256,708.4675,989View SEC Filing  
1/20/2016Kevin R SayerCEOSell7,000$75.00$525,000.00336,402View SEC Filing  
1/12/2016Jorge A ValdesInsiderSell5,610$80.16$449,697.6092,437View SEC Filing  
1/11/2016Jorge A ValdesInsiderSell1,641$78.43$128,703.6392,437View SEC Filing  
1/8/2016John ListerVPSell3,560$82.57$293,949.2097,710View SEC Filing  
12/23/2015Richard DoubledayEVPSell1,666$82.22$136,978.52100,483View SEC Filing  
12/22/2015Jess RoperCFOSell3,417$81.19$277,426.2379,507View SEC Filing  
12/17/2015Andrew K. BaloEVPSell7,500$82.52$618,900.00107,680View SEC Filing  
12/14/2015John ListerVPSell3,560$82.50$293,700.00101,270View SEC Filing  
12/9/2015Jorge A. ValdesinsiderSell10,000$85.74$857,400.0092,437View SEC Filing  
12/8/2015John ListerVPSell2,476$87.16$215,808.16104,830View SEC Filing  
12/4/2015Terrance H. GreggChairmanSell10,000$86.79$867,900.00459,018View SEC Filing  
12/3/2015Andrew K. BaloEVPSell7,500$86.37$647,775.00107,680View SEC Filing  
12/2/2015Terrance H. GreggChairmanSell10,000$87.05$870,500.00459,018View SEC Filing  
11/30/2015Terrance H. GreggChairmanSell5,000$86.50$432,500.00459,018View SEC Filing  
11/25/2015Andrew K. BaloEVPSell7,500$87.49$656,175.00107,680View SEC Filing  
11/25/2015Terrance H. GreggChairmanSell15,000$87.53$1,312,950.00459,018View SEC Filing  
11/24/2015Andrew K. BaloEVPSell10,000$86.43$864,300.00107,680View SEC Filing  
11/24/2015Terrance H. GreggChairmanSell15,497$86.54$1,341,110.38459,018View SEC Filing  
11/23/2015Richard DoubledayEVPSell1,666$85.85$143,026.10100,483View SEC Filing  
11/20/2015Terrance H. GreggChairmanSell22,003$86.48$1,902,819.44459,018View SEC Filing  
11/18/2015Jess RoperCFOSell7,000$84.15$589,050.0082,924View SEC Filing  
11/16/2015Terrance H. GreggChairmanSell20,000$83.89$1,677,800.00459,018View SEC Filing  
11/12/2015Jess RoperCFOSell20,000$84.07$1,681,400.0083,924View SEC Filing  
11/11/2015Andrew K. BaloEVPSell7,500$84.50$633,750.00113,157View SEC Filing  
10/23/2015Richard DoubledayEVPSell1,666$79.27$132,063.82100,483View SEC Filing  
10/20/2015Andrew K BaloEVPSell4,538$81.46$369,665.48113,157View SEC Filing  
10/19/2015Jess RoperCFOSell7,000$83.37$583,590.0098,424View SEC Filing  
10/15/2015Terrance H GreggChairmanSell15,000$77.92$1,168,800.00459,018View SEC Filing  
10/6/2015Andrew K BaloEVPSell8,216$82.29$676,094.64117,695View SEC Filing  
9/23/2015Steven Robert PacelliEVPSell14,000$98.08$1,373,120.00216,214View SEC Filing  
9/21/2015Andrew K BaloEVPSell7,859$100.72$791,558.48125,911View SEC Filing  
9/18/2015Jess RoperCFOSell7,000$101.22$708,540.0099,424View SEC Filing  
9/15/2015Terrance H. GreggChairmanSell29,999$96.22$2,886,503.78459,018View SEC Filing  
9/11/2015Terrance H. GreggChairmanSell47,500$96.50$4,583,750.00459,018View SEC Filing  
9/10/2015Terrance H. GreggChairmanSell62,501$95.91$5,994,470.91459,018View SEC Filing  
9/9/2015Jonathan T Md LordDirectorSell10,000$90.96$909,600.00131,582View SEC Filing  
9/8/2015Andrew K BaloEVPSell7,500$89.53$671,475.00142,590View SEC Filing  
9/8/2015John ListerVPSell2,642$89.36$236,089.12121,347View SEC Filing  
9/8/2015Terrance H. GreggChairmanSell25,000$90.85$2,271,250.00459,018View SEC Filing  
9/1/2015Jeffrey MoySVPSell8,881$90.61$804,707.4190,000View SEC Filing  
9/1/2015Jorge A. ValdesinsiderSell20,000$91.22$1,824,400.00116,207View SEC Filing  
8/28/2015Steven Robert PacelliEVPSell19,854$94.67$1,879,578.18228,792View SEC Filing  
8/24/2015Steven Robert PacelliEVPSell14,000$84.18$1,178,520.00248,646View SEC Filing  
8/20/2015Andrew K BaloEVPSell7,500$92.47$693,525.00150,090View SEC Filing  
8/18/2015Steven R AltmanDirectorSell5,000$96.69$483,450.00View SEC Filing  
8/17/2015Jay S SkylerDirectorSell20,000$96.65$1,933,000.00View SEC Filing  
8/17/2015Terrance H GreggChairmanSell15,000$96.71$1,450,650.00View SEC Filing  
8/14/2015Kevin R SayerCEOSell35,000$97.41$3,409,350.00View SEC Filing  
7/23/2015Richard DoubledayEVPSell9,641$85.37$823,052.17View SEC Filing  
7/22/2015Andrew K BaloEVPSell10,214$84.78$865,942.92View SEC Filing  
7/21/2015Jeffrey MoySVPSell3,786$83.48$316,055.28View SEC Filing  
7/20/2015Jess RoperCFOSell7,000$83.74$586,180.00View SEC Filing  
7/17/2015Terrance H GreggChairmanSell50,750$83.07$4,215,802.50View SEC Filing  
7/15/2015Jay S SkylerDirectorSell20,000$81.69$1,633,800.00View SEC Filing  
7/8/2015Andrew K BaloEVPSell4,494$80.22$360,508.68View SEC Filing  
7/8/2015John ListerVPSell1,776$79.94$141,973.44View SEC Filing  
7/8/2015Jorge A ValdesInsiderSell50,000$79.83$3,991,500.00View SEC Filing  
7/7/2015Jeffrey MoySVPSell5,000$79.32$396,600.00View SEC Filing  
6/23/2015Jeffrey MoySVPSell5,154$77.54$399,641.16View SEC Filing  
6/23/2015Steven Robert PacelliEVPSell14,000$77.53$1,085,420.00View SEC Filing  
6/18/2015Jess RoperCFOSell7,000$77.10$539,700.00View SEC Filing  
6/15/2015Jay S SkylerDirectorSell20,000$70.67$1,413,400.00View SEC Filing  
6/15/2015Terrance H GreggChairmanSell15,000$70.94$1,064,100.00View SEC Filing  
6/12/2015Terrance H. GreggChairmanSell25,000$72.30$1,807,500.00459,018View SEC Filing  
6/11/2015Jeffrey MoySVPSell9,869$73.00$720,437.00View SEC Filing  
6/9/2015Andrew K BaloEVPSell7,500$70.62$529,650.00View SEC Filing  
6/9/2015Jeffrey MoySVPSell5,000$70.63$353,150.00View SEC Filing  
6/9/2015Jorge A ValdesInsiderSell19,680$71.32$1,403,577.60View SEC Filing  
6/8/2015John ListerVPSell1,776$72.03$127,925.28View SEC Filing  
6/8/2015Jorge A ValdesInsiderSell8,243$72.07$594,073.01View SEC Filing  
6/3/2015Terrance H GreggChairmanSell40,000$72.77$2,910,800.00View SEC Filing  
6/2/2015Terrance H GreggChairmanSell5,000$73.12$365,600.00View SEC Filing  
6/1/2015Terrance H GreggChairmanSell10,000$72.75$727,500.00View SEC Filing  
5/27/2015Jeffrey MoySVPSell21,791$69.60$1,516,653.60View SEC Filing  
5/27/2015Richard DoubledayEVPSell3,258$70.73$230,438.34View SEC Filing  
5/18/2015Andrew K BaloEVPSell7,500$68.46$513,450.00View SEC Filing  
5/18/2015Jeffrey MoySVPSell15,586$69.20$1,078,551.20View SEC Filing  
5/18/2015Jess RoperCFOSell7,000$69.27$484,890.00View SEC Filing  
5/15/2015Terrance H GreggChairmanSell82,500$69.24$5,712,300.00View SEC Filing  
5/12/2015Jeffrey MoySVPSell20,303$67.84$1,377,355.52View SEC Filing  
5/12/2015Jorge A ValdesInsiderSell30,878$68.27$2,108,041.06View SEC Filing  
5/11/2015Jeffrey MoySVPSell15,303$68.25$1,044,429.75View SEC Filing  
5/11/2015Terrance H GreggChairmanSell3,517$68.65$241,442.05View SEC Filing  
5/8/2015Terrance H GreggChairmanSell91,483$67.85$6,207,121.55View SEC Filing  
5/4/2015Kevin R SayerCEOSell25,000$68.01$1,700,250.00View SEC Filing  
4/28/2015Jeffrey MoySVPSell10,000$68.41$684,100.00View SEC Filing  
4/27/2015Jeffrey MoySVPSell5,000$69.27$346,350.00View SEC Filing  
4/23/2015Steven Robert PacelliEVPSell39,709$69.63$2,764,937.67View SEC Filing  
4/20/2015Jess RoperCFOSell7,000$68.05$476,350.00View SEC Filing  
4/15/2015Terrance H GreggChairmanSell15,000$67.56$1,013,400.00View SEC Filing  
4/14/2015Jeffrey MoySVPSell20,766$66.63$1,383,638.58View SEC Filing  
4/9/2015Andrew K BaloEVPSell7,500$64.55$484,125.00View SEC Filing  
4/9/2015Jorge A ValdesInsiderSell19,684$64.38$1,267,255.92View SEC Filing  
4/8/2015John ListerVPSell5,039$63.84$321,689.76View SEC Filing  
3/25/2015Andrew K BaloEVPSell7,500$61.05$457,875.00View SEC Filing  
3/23/2015Steven Robert PacelliEVPSell14,000$61.33$858,620.00View SEC Filing  
3/18/2015Jess RoperCFOSell7,000$62.43$437,010.00View SEC Filing  
3/17/2015Terrance H GreggChairmanSell15,000$62.82$942,300.00View SEC Filing  
3/13/2015Jay S SkylerDirectorSell45,000$60.01$2,700,450.00View SEC Filing  
3/12/2015Jorge A ValdesInsiderSell11,138$59.78$665,829.64View SEC Filing  
3/12/2015Richard DoubledayEVPSell20,000$59.23$1,184,600.00View SEC Filing  
3/9/2015John ListerVPSell5,039$58.77$296,142.03View SEC Filing  
3/9/2015Jorge A ValdesInsiderSell8,244$58.77$484,499.88View SEC Filing  
2/23/2015Richard DoubledayEVPSell4,000$63.58$254,320.00View SEC Filing  
2/9/2015John ListerVPSell5,039$61.66$310,704.74View SEC Filing  
2/9/2015Jorge A ValdesInsiderSell8,244$61.67$508,407.48View SEC Filing  
2/2/2015Jeffrey MoySVPSell5,000$60.69$303,450.00View SEC Filing  
1/26/2015Steven Robert PacelliEVPSell24,532$59.67$1,463,824.44View SEC Filing  
1/23/2015Richard DoubledayEVPSell4,000$58.22$232,880.00View SEC Filing  
1/20/2015Jeffrey MoySVPSell5,000$57.58$287,900.00View SEC Filing  
1/20/2015Jess RoperCFOSell7,000$57.34$401,380.00View SEC Filing  
1/15/2015Terrance H GreggChairmanSell15,000$57.84$867,600.00View SEC Filing  
1/13/2015Steven Robert PacelliEVPSell9,468$62.22$589,098.96View SEC Filing  
1/12/2015Steven Robert PacelliEVPSell20,000$59.18$1,183,600.00View SEC Filing  
1/9/2015Jorge A ValdesInsiderSell9,170$57.55$527,733.50View SEC Filing  
1/8/2015John ListerVPSell5,039$57.42$289,339.38View SEC Filing  
1/5/2015Jeffrey MoySVPSell5,000$55.27$276,350.00View SEC Filing  
12/26/2014Andrew K BaloSVPSell10,000$55.27$552,700.00View SEC Filing  
12/23/2014Richard DoubledayVPSell4,000$54.69$218,760.00View SEC Filing  
12/23/2014Steven Robert PacelliEVPSell14,000$54.62$764,680.00View SEC Filing  
12/18/2014Jess RoperCFOSell12,000$56.43$677,160.00View SEC Filing  
12/15/2014Terrance H GreggCEOSell35,000$53.23$1,863,050.00View SEC Filing  
12/8/2014Jorge A ValdesInsiderSell16,000$56.03$896,480.00View SEC Filing  
12/3/2014Eric TopolDirectorSell20,000$55.00$1,100,000.00View SEC Filing  
11/28/2014Terrance H GreggCEOSell59,990$51.51$3,090,084.90View SEC Filing  
11/25/2014Andrew K BaloSVPSell10,000$51.11$511,100.00View SEC Filing  
11/25/2014Terrance H GreggCEOSell55,010$51.04$2,807,710.40View SEC Filing  
11/24/2014Richard DoubledayVPSell4,000$50.36$201,440.00View SEC Filing  
11/24/2014Terrance H GreggCEOSell35,000$51.06$1,787,100.00View SEC Filing  
11/21/2014Terrance H GreggCEOSell10,000$50.50$505,000.00View SEC Filing  
11/19/2014Terrance H GreggCEOSell10,000$51.00$510,000.00View SEC Filing  
11/17/2014Terrance H GreggCEOSell45,000$52.52$2,363,400.00View SEC Filing  
11/12/2014Terrance H GreggCEOSell80,000$53.36$4,268,800.00View SEC Filing  
11/10/2014Jorge A ValdesInsiderSell16,000$51.23$819,680.00View SEC Filing  
10/27/2014Andrew K BaloSVPSell10,000$42.98$429,800.00View SEC Filing  
10/23/2014Richard DoubledayVPSell4,000$43.58$174,320.00View SEC Filing  
10/23/2014Steven Robert PacelliEVPSell14,000$43.60$610,400.00View SEC Filing  
10/13/2014Andrew K BaloSVPSell10,000$40.42$404,200.00View SEC Filing  
10/13/2014John ListerVPSell3,400$40.41$137,394.00View SEC Filing  
10/8/2014Jorge A ValdesInsiderSell16,000$40.29$644,640.00View SEC Filing  
9/25/2014Andrew K BaloSVPSell10,000$40.71$407,100.00View SEC Filing  
9/23/2014Richard DoubledayVPSell4,000$40.32$161,280.00View SEC Filing  
9/23/2014Steven Robert PacelliEVPSell14,000$40.32$564,480.00View SEC Filing  
9/18/2014Jess RoperCFOSell8,000$41.91$335,280.00View SEC Filing  
9/15/2014Terrance H GreggCEOSell35,000$41.14$1,439,900.00View SEC Filing  
9/12/2014John ListerVPSell3,518$43.70$153,736.60View SEC Filing  
9/11/2014Andrew K BaloSVPSell10,000$42.97$429,700.00View SEC Filing  
9/8/2014Jorge A ValdesInsiderSell16,000$42.98$687,680.00View SEC Filing  
8/28/2014Barbara KahnDirectorSell4,000$44.52$178,080.00View SEC Filing  
8/26/2014Jeffrey MoySVPSell16,663$45.30$754,833.90View SEC Filing  
8/26/2014Jonathan T Md LordDirectorSell20,000$45.56$911,200.00View SEC Filing  
8/26/2014Steven Robert PacelliEVPSell30,000$44.56$1,336,800.00View SEC Filing  
8/26/2014Terrance H GreggCEOSell5,000$46.05$230,250.00View SEC Filing  
8/25/2014Andrew K BaloSVPSell10,000$44.12$441,200.00View SEC Filing  
8/25/2014Richard DoubledayVPSell4,000$44.35$177,400.00View SEC Filing  
8/25/2014Steven Robert PacelliEVPSell14,000$44.24$619,360.00View SEC Filing  
8/22/2014Andrew K BaloSVPSell20,000$44.24$884,800.00View SEC Filing  
8/22/2014Terrance H GreggCEOSell13,607$44.46$604,967.22View SEC Filing  
8/21/2014Barbara KahnDirectorSell2,200$43.42$95,524.00View SEC Filing  
8/21/2014Jorge A ValdesInsiderSell10,671$43.58$465,042.18View SEC Filing  
8/21/2014Terrance H GreggCEOSell23,893$44.36$1,059,893.48View SEC Filing  
8/19/2014Richard DoubledayVPSell20,000$45.01$900,200.00View SEC Filing  
8/19/2014Terrance H GreggCEOSell75,000$45.08$3,381,000.00View SEC Filing  
8/18/2014Terrance H GreggCEOSell65,000$44.16$2,870,400.00View SEC Filing  
8/14/2014Terrance H GreggCEOSell25,000$44.24$1,106,000.00View SEC Filing  
8/13/2014Terrance H GreggCEOSell56,107$43.57$2,444,581.99View SEC Filing  
8/11/2014Andrew K BaloSVPSell10,000$44.24$442,400.00View SEC Filing  
8/11/2014Kevin R SayerCOOSell20,000$43.82$876,400.00View SEC Filing  
8/8/2014Jorge A ValdesInsiderSell16,000$43.56$696,960.00View SEC Filing  
7/25/2014Andrew K BaloSVPSell10,000$38.19$381,900.00View SEC Filing  
7/23/2014Richard DoubledayVPSell4,000$38.16$152,640.00View SEC Filing  
7/23/2014Steven Robert PacelliEVPSell14,000$38.28$535,920.00View SEC Filing  
7/18/2014Jess RoperCFOSell8,000$36.01$288,080.00View SEC Filing  
7/15/2014Terrance H GreggCEOSell35,000$36.66$1,283,100.00View SEC Filing  
7/14/2014John ListerVPSell3,500$36.59$128,065.00View SEC Filing  
7/11/2014Andrew K BaloSVPSell10,000$35.93$359,300.00View SEC Filing  
7/8/2014Jorge A ValdesInsiderSell16,000$36.66$586,560.00View SEC Filing  
7/2/2014Jay S SkylerDirectorSell30,000$40.05$1,201,500.00View SEC Filing  
6/25/2014Andrew K BaloSVPSell10,000$40.60$406,000.00View SEC Filing  
6/23/2014Richard DoubledayVPSell4,000$40.98$163,920.00View SEC Filing  
6/23/2014Steven Robert PacelliEVPSell14,000$41.02$574,280.00View SEC Filing  
6/20/2014Jay S SkylerDirectorSell60,000$40.00$2,400,000.00View SEC Filing  
6/18/2014Jess RoperCFOSell8,000$39.17$313,360.00View SEC Filing  
6/16/2014Terrance H GreggCEOSell35,000$37.23$1,303,050.00View SEC Filing  
6/12/2014John ListerVPSell3,500$36.13$126,455.00View SEC Filing  
6/11/2014Andrew K BaloSVPSell10,000$36.63$366,300.00View SEC Filing  
6/9/2014Jorge A ValdesInsiderSell16,000$36.68$586,880.00View SEC Filing  
6/5/2014Richard DoubledayVPSell4,000$35.59$142,360.00View SEC Filing  
5/27/2014Andrew K BaloSVPSell10,000$33.86$338,600.00View SEC Filing  
5/19/2014Jess RoperCFOSell8,000$32.20$257,600.0087,786View SEC Filing  
5/8/2014Jorge ValdesInsiderSell16,000$29.83$477,280.00217,487View SEC Filing  
4/25/2014Andrew BaloSVPSell10,000$34.35$343,500.00159,099View SEC Filing  
4/23/2014Richard DoubledayVPSell4,000$35.92$143,680.00147,523View SEC Filing  
4/23/2014Steven Robert PacelliEVPSell14,000$35.90$502,600.00241,399View SEC Filing  
4/21/2014Jess RoperCFOSell8,000$36.18$289,440.0087,786View SEC Filing  
4/15/2014Terrance GreggCEOSell35,000$34.09$1,193,150.00395,626View SEC Filing  
4/14/2014John ListerVPSell2,884$35.86$103,420.24119,408View SEC Filing  
4/11/2014Andrew BaloSVPSell10,000$35.36$353,600.00159,099View SEC Filing  
4/8/2014Jorge ValdesInsiderSell16,000$35.99$575,840.00217,487View SEC Filing  
3/26/2014Jay SkylerDirectorSell30,000$43.05$1,291,500.00View SEC Filing  
3/25/2014Andrew BaloSVPSell10,000$43.00$430,000.00159,099View SEC Filing  
3/24/2014Steven Robert PacelliEVPSell14,000$42.92$600,880.00241,399View SEC Filing  
3/18/2014Jess RoperCFOSell8,000$46.00$368,000.0087,786View SEC Filing  
3/17/2014Terrance GreggCEOSell45,000$45.25$2,036,250.00395,626View SEC Filing  
3/12/2014Terrance GreggCEOSell30,000$45.50$1,365,000.00395,626View SEC Filing  
3/10/2014Jorge ValdesInsiderSell16,000$46.57$745,120.00203,003View SEC Filing  
3/5/2014Jeffrey MoySVPSell10,000$47.30$473,000.00187,485View SEC Filing  
3/5/2014Terrance GreggCEOSell111,890$47.46$5,310,299.40212,813View SEC Filing  
3/3/2014Terrance GreggCEOSell40,000$44.87$1,794,800.00212,813View SEC Filing  
2/26/2014Jess RoperCFOSell25,000$45.20$1,130,000.0066,508View SEC Filing  
2/25/2014Steven Robert PacelliEVPSell33,368$44.93$1,499,224.24195,865View SEC Filing  
1/23/2014Steven Robert PacelliEVPSell14,000$36.49$510,860.00195,865View SEC Filing  
1/21/2014Jess RoperCFOSell8,000$37.38$299,040.0065,808View SEC Filing  
12/18/2013Jess RoperCFOSell8,000$34.48$275,840.0065,808View SEC Filing  
12/13/2013Terrance GreggCEOSell50,000$34.41$1,720,500.00212,813View SEC Filing  
12/12/2013Nicholas AugustinosDirectorSell11,321$34.40$389,442.4011,130View SEC Filing  
12/10/2013Nicholas AugustinosDirectorSell97,541$33.64$3,281,279.2422,451View SEC Filing  
12/5/2013Terrance GreggCEOSell20,000$34.77$695,400.00212,813View SEC Filing  
12/3/2013Andrew BaloSVPSell14,268$34.21$488,108.28124,297View SEC Filing  
11/15/2013Terrance GreggCEOSell35,000$32.74$1,145,900.00212,813View SEC Filing  
9/3/2013Terrance GreggCEOSell9,000$27.00$243,000.00212,813View SEC Filing  
8/1/2013Terrance H GreggCEOSell9,000$22.15$199,350.00View SEC Filing  
7/1/2013Terrance H GreggCEOSell9,000$22.87$205,830.00View SEC Filing  
6/13/2013Andrew K BaloSVPSell10,000$21.90$219,000.00View SEC Filing  
6/11/2013Jess RoperCFOSell10,361$22.33$231,361.13View SEC Filing  
6/11/2013John ListerVPSell2,000$22.43$44,860.00View SEC Filing  
6/11/2013Steven Robert PacelliEVPSell5,000$22.31$111,550.00View SEC Filing  
6/4/2013Terrance H GreggCEOSell19,000$21.32$405,080.00View SEC Filing  
5/15/2013Jeffrey MoySVPSell5,000$19.97$99,850.00View SEC Filing  
5/13/2013Andrew K BaloSVPSell45,000$19.40$873,000.00View SEC Filing  
5/9/2013Richard DoubledaySVPSell1,272$19.56$24,880.32View SEC Filing  
3/13/2013Andrew K BaloSVPSell15,416$16.53$254,826.48View SEC Filing  
3/11/2013Jay S SkylerDirectorBuy70,000$15.50$1,085,000.00View SEC Filing  
3/11/2013John ListerVPSell4,500$15.75$70,875.00View SEC Filing  
3/11/2013Richard DoubledaySVPSell5,100$15.63$79,713.00View SEC Filing  
2/1/2013Terrance H GreggCEOSell9,000$15.08$135,720.00View SEC Filing  
12/3/2012Terrance H GreggCEOSell5,000$13.24$66,200.00View SEC Filing  
9/4/2012Terrance H GreggCEOSell15,000$13.46$201,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Dexcom (NASDAQ DXCM) News Headlines

Source:
DateHeadline
Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLet™ Bionic ...Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLet™ Bionic ...
globenewswire.com - May 21 at 9:04 AM
Dexcom (DXCM) Receives Consensus Rating of "Buy" from AnalystsDexcom (DXCM) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - May 20 at 5:43 AM
Insider Selling: Dexcom (DXCM) Insider Sells 10,000 Shares of StockInsider Selling: Dexcom (DXCM) Insider Sells 10,000 Shares of Stock
www.americanbankingnews.com - May 17 at 7:55 PM
Jay S. Skyler Sells 30,000 Shares of Dexcom (DXCM) StockJay S. Skyler Sells 30,000 Shares of Dexcom (DXCM) Stock
www.americanbankingnews.com - May 16 at 10:15 PM
$204.34 Million in Sales Expected for Dexcom (DXCM) This Quarter$204.34 Million in Sales Expected for Dexcom (DXCM) This Quarter
www.americanbankingnews.com - May 15 at 3:06 AM
Zacks: Analysts Expect Dexcom (DXCM) Will Announce Earnings of -$0.20 Per ShareZacks: Analysts Expect Dexcom (DXCM) Will Announce Earnings of -$0.20 Per Share
www.americanbankingnews.com - May 13 at 11:09 AM
Dexcom's newest diabetes device can read your blood sugar without any blood, and it's a life-changerDexcom's newest diabetes device can read your blood sugar without any blood, and it's a life-changer
finance.yahoo.com - May 13 at 9:38 AM
This diabetes monitor can read your blood sugar without any bloodThis diabetes monitor can read your blood sugar without any blood
www.cnbc.com - May 12 at 9:54 AM
Dexcoms newest diabetes device can read your blood sugar without any blood, and its a life-changerDexcom's newest diabetes device can read your blood sugar without any blood, and it's a life-changer
finance.yahoo.com - May 12 at 9:54 AM
Dexcom (DXCM) Upgraded to "C-" at TheStreetDexcom (DXCM) Upgraded to "C-" at TheStreet
www.americanbankingnews.com - May 12 at 7:35 AM
Bank of America Begins Coverage on Dexcom (DXCM)Bank of America Begins Coverage on Dexcom (DXCM)
www.americanbankingnews.com - May 11 at 5:49 PM
Jacob Steven Leach Sells 1,923 Shares of Dexcom (DXCM) StockJacob Steven Leach Sells 1,923 Shares of Dexcom (DXCM) Stock
www.americanbankingnews.com - May 10 at 10:32 PM
Kevin R. Sayer Sells 17,245 Shares of Dexcom (DXCM) StockKevin R. Sayer Sells 17,245 Shares of Dexcom (DXCM) Stock
www.americanbankingnews.com - May 10 at 10:15 PM
Jay S. Skyler Sells 31,464 Shares of Dexcom (DXCM) StockJay S. Skyler Sells 31,464 Shares of Dexcom (DXCM) Stock
www.americanbankingnews.com - May 9 at 10:14 PM
Research Analysts Set Expectations for Dexcoms Q2 2018 Earnings (DXCM)Research Analysts Set Expectations for Dexcom's Q2 2018 Earnings (DXCM)
www.americanbankingnews.com - May 7 at 2:26 AM
Jefferies Group Comments on Dexcoms Q2 2018 Earnings (DXCM)Jefferies Group Comments on Dexcom's Q2 2018 Earnings (DXCM)
www.americanbankingnews.com - May 7 at 2:26 AM
Dexcom (DXCM) Expected to Post Q2 2018 Earnings of ($0.19) Per ShareDexcom (DXCM) Expected to Post Q2 2018 Earnings of ($0.19) Per Share
www.americanbankingnews.com - May 7 at 2:26 AM
Q2 2018 Earnings Forecast for Dexcom (DXCM) Issued By Piper JaffrayQ2 2018 Earnings Forecast for Dexcom (DXCM) Issued By Piper Jaffray
www.americanbankingnews.com - May 7 at 2:26 AM
Dexcom (DXCM) Given New $70.00 Price Target at Morgan StanleyDexcom (DXCM) Given New $70.00 Price Target at Morgan Stanley
www.americanbankingnews.com - May 5 at 3:01 AM
DexCom (DXCM) Meets Q1 Earnings Estimates, Raises '18 ViewDexCom (DXCM) Meets Q1 Earnings Estimates, Raises '18 View
finance.yahoo.com - May 4 at 4:35 PM
Abbott’s Freestyle Libre CGM’s Performance, Growth ProspectsAbbott’s Freestyle Libre CGM’s Performance, Growth Prospects
finance.yahoo.com - May 4 at 4:35 PM
William Blair Analysts Boost Earnings Estimates for Dexcom (DXCM)William Blair Analysts Boost Earnings Estimates for Dexcom (DXCM)
www.americanbankingnews.com - May 4 at 10:26 AM
DexCom (DXCM) Meets Q1 Earnings Estimates, Raises 18 ViewDexCom (DXCM) Meets Q1 Earnings Estimates, Raises '18 View
www.zacks.com - May 4 at 9:12 AM
Q4 2018 EPS Estimates for Dexcom (DXCM) Decreased by Piper JaffrayQ4 2018 EPS Estimates for Dexcom (DXCM) Decreased by Piper Jaffray
www.americanbankingnews.com - May 4 at 8:37 AM
Dexcom (DXCM) to Post Q4 2018 Earnings of $0.08 Per Share, Oppenheimer ForecastsDexcom (DXCM) to Post Q4 2018 Earnings of $0.08 Per Share, Oppenheimer Forecasts
www.americanbankingnews.com - May 4 at 8:36 AM
Dexcom (DXCM) Upgraded to "Buy" at ValuEngineDexcom (DXCM) Upgraded to "Buy" at ValuEngine
www.americanbankingnews.com - May 3 at 11:47 PM
Dexcom (DXCM) PT Raised to $85.00Dexcom (DXCM) PT Raised to $85.00
www.americanbankingnews.com - May 3 at 11:42 PM
Dexcom (DXCM) Price Target Raised to $86.00Dexcom (DXCM) Price Target Raised to $86.00
www.americanbankingnews.com - May 3 at 8:35 PM
Dexcom (DXCM) Price Target Increased to $85.00 by Analysts at OppenheimerDexcom (DXCM) Price Target Increased to $85.00 by Analysts at Oppenheimer
www.americanbankingnews.com - May 3 at 8:35 PM
BTIG Research Reaffirms Hold Rating for Dexcom (DXCM)BTIG Research Reaffirms Hold Rating for Dexcom (DXCM)
www.americanbankingnews.com - May 3 at 6:46 PM
Heres Why DexCom Is Surging TodayHere's Why DexCom Is Surging Today
www.fool.com - May 3 at 4:34 PM
Here's Why DexCom Is Surging TodayHere's Why DexCom Is Surging Today
finance.yahoo.com - May 3 at 4:34 PM
BRIEF-DexCom Reports Q1 GAAP Loss Per Share Of $0.28BRIEF-DexCom Reports Q1 GAAP Loss Per Share Of $0.28
www.reuters.com - May 3 at 9:09 AM
DexCom (DXCM) Q1 2018 Results - Earnings Call TranscriptDexCom (DXCM) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 3 at 9:09 AM
Edited Transcript of DXCM earnings conference call or presentation 2-May-18 8:30pm GMTEdited Transcript of DXCM earnings conference call or presentation 2-May-18 8:30pm GMT
finance.yahoo.com - May 3 at 9:09 AM
DexCom: 1Q Earnings SnapshotDexCom: 1Q Earnings Snapshot
finance.yahoo.com - May 3 at 9:09 AM
Dexcom (DXCM) Issues Quarterly  Earnings ResultsDexcom (DXCM) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 2 at 10:42 PM
DexCom Reports First Quarter 2018 Financial ResultsDexCom Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 2 at 4:41 PM
DexCom beats by $0.01, beats on revenueDexCom beats by $0.01, beats on revenue
seekingalpha.com - May 2 at 4:11 PM
Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin PumpTandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump
www.businesswire.com - April 30 at 9:26 AM
Zacks: Brokerages Anticipate Dexcom (DXCM) Will Announce Quarterly Sales of $172.68 MillionZacks: Brokerages Anticipate Dexcom (DXCM) Will Announce Quarterly Sales of $172.68 Million
www.americanbankingnews.com - April 28 at 5:34 AM
Dexcom (DXCM) Short Interest UpdateDexcom (DXCM) Short Interest Update
www.americanbankingnews.com - April 27 at 2:58 AM
Dexcom (DXCM) Expected to Post Earnings of -$0.32 Per ShareDexcom (DXCM) Expected to Post Earnings of -$0.32 Per Share
www.americanbankingnews.com - April 26 at 1:24 AM
Dexcom (DXCM) EVP Sells $188,645.29 in StockDexcom (DXCM) EVP Sells $188,645.29 in Stock
www.americanbankingnews.com - April 25 at 10:18 PM
Dexcom (DXCM) Receives Average Recommendation of "Buy" from BrokeragesDexcom (DXCM) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 25 at 5:38 AM
New Review of Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach ...New Review of Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach ...
www.prnewswire.com - April 24 at 9:14 AM
Dexcom (DXCM) Set to Announce Earnings on MondayDexcom (DXCM) Set to Announce Earnings on Monday
www.americanbankingnews.com - April 23 at 7:32 AM
Form 4 DEXCOM INC For: Apr 16 Filed by: GREGG TERRANCE HForm 4 DEXCOM INC For: Apr 16 Filed by: GREGG TERRANCE H
www.streetinsider.com - April 19 at 9:14 AM
Head to Head Contrast: Dexcom (DXCM) & Baxter International (BAX)Head to Head Contrast: Dexcom (DXCM) & Baxter International (BAX)
www.americanbankingnews.com - April 19 at 8:42 AM
Dexcom (DXCM) Raised to Hold at Zacks Investment ResearchDexcom (DXCM) Raised to Hold at Zacks Investment Research
www.americanbankingnews.com - April 17 at 5:27 PM

SEC Filings

Dexcom (NASDAQ:DXCM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Dexcom (NASDAQ:DXCM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Dexcom (NASDAQ DXCM) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.